STRATEGIC ANALYSIS OF THE WORLD PHARMACEUTICAL INDUSTRY Dragan Kesič∗ Received: 28. 2. 2007 Case study Accepted: 9. 7. 2008 UDC 65.01:615 The world pharmaceutical industry has been changing profoundly in the last decade. Intensive globalization‚ increased competitiveness and the fight for global market shares create new challenges for pharmaceutical companies. Fast globalization definitively reinforces the consolidation of the world pharmaceutical industry. Alliancing in forms of mergers and
Premium Pharmaceutical industry Generic drug Marketing
The Pharmaceutical Industry “The word medicine is derived from the Latin ars medicine‚ meaning the art of healing.” Medicine is the art and science of healing as practiced by physicians and similar professionals and encompasses all sciences related to it. It is the applied science or practice of the diagnosis‚ treatment and preventions of diseases. It is a variety of health care practices involved in to maintain and restore health by preventing and treatment of different sickness in human beings
Premium Greek mythology Apollo Allergy
Industry Analysis: Pharmaceutical Preparations Macro and Micro Analysis Macro & Micro Industry Analysis: Pharmaceuticals subgroup: Pharmaceutical preparations The report analyses the macro and micro-environmental factors of the industrial group called “Manufacture of pharmaceutical preparations” with the standard industrial code of 21200‚ according to the most recent version of the UK Standard Industrial Classification (SIC) of 2007. (Office for National Statistics‚ 2007) Although different
Premium Pharmaceutical industry Novartis
The History and Analysis of the Pharmaceutical Industry Pharmaceuticals Industry Analysis i 1. Origins and Evolution 2 2. Environmental Analysis (PEST) 2 3. Structural Industry Analysis (Porter’s Five Forces) 4 4. Strategic Issues Facing The Industry 5 5. Analysis of Key Industry Participants and Strategy 6 6. Pfizer – SWOT Analysis and Strategy Review 8 7. Conclusion 10 8. References 10 Pharmaceuticals Industry Analysis Page 1 Executive Summary This report provides an analytical strategic
Premium Strategic management SWOT analysis Pharmaceutical industry
Global Pharmaceutical Industry Analysis September 21 2009 Dibakar Mitra (P08017) I Manoj Joshi (B08026) Table of Contents EXECUTIVE SUMMARY 3 INTRODUCTION 4 ORIGIN AND EVOLUTION 5 ENVIRONMENT ANALYSIS (PEST) 7 STRUCTURAL INDUSTRY ANALYSIS (PORTER) 8 STRATEGIC ISSUES FACING THE INDUSTRY 11 STRATEGIC GROUPS IN THE INDUSTRY ACCORDING TO MARKET/DRUG/FUNCTIONING 15 PROCESS FLOW: IMPORTANT FUNCTIONS 16 STRATEGIC RESPONSES TO CHALLENGES: SIMPLE CORRELATION BETWEEN GROUP
Premium Pharmaceutical industry
Major firms of the world pharmaceutical industry Pharmaceutical industry is characterized by high level of concentration. There are about dozen of multinational companies that dominate in industry. Most of companies are not widely diversified and more than 50% of revenues come from sales of pharmaceutical products. There are few companies in industry that have other large sources of income‚ for example Johnson & Johnson. The pharmaceutical industry has two distinct functions:
Premium Pharmaceutical industry Pharmacology Generic drug
PHARMACEUTICAL INDUSTRY ANALYSIS Industry Background: The total industry can broadly be classified into two categories. These are a) Patent Medicines b) Generic Medicines Patent medicines are the products that are invented by the company‚ who have their own research team working on their own laboratories. These products are patented for many years to enjoy the monopoly market. After years of business the formulation is sold in the market so that others can go into mass production. Generic
Premium Pharmaceutical industry Pharmacology
Summer Internship Project In Depth Fundamental Analysis of Pharmaceutical Industry Submitted in partial fulfillment of PGDM program 2009-11 [pic] Submitted by Vikas Khandelwal 17/058 Company Guide Faculty Guide Name: Mr. Ritesh Purohit Name: Ms. Ruchi Paliwal Assistant Vice President Globe Capital Market Ltd. Apeejay School of Management New Delhi July 2010 ACKNOWLEDGEMENT This project would have been difficult to complete without the invaluable contributions
Premium Stock market Fundamental analysis Technical analysis
The Global Pharmaceutical Industry Date: 2011 August 20 Table of content Contents Page 1. Introduction 4 2. Pestel analysis of the global pharmaceutical industries 5-6 3. Drivers for change in the future of pharmaceutical 7 4. Five forces analysis on the global pharmaceutical industry 8-10 5. Threats to a big pharmaceutical company 11 6. Conclusion 12 7. Bibliography 13 Introduction The pharmaceutical industry According
Premium Pharmaceutical industry Generic drug Barriers to entry
Indian Pharmaceutical Industry Business Environment 3 Agenda • • • • • • • History Indian Pharmaceutical Evolution Facts and Figures Regulatory Framework Current ongoing activities SWOT Analysis The India Advantage 4 History • Bengal Chemicals and Pharmaceutical Works‚ Calcutta‚ the first Indian pharmaceutical company established in 1901 • Still exists as one of the 5 government owned drug manufacturers • Next 60 years saw most of the drugs imported from multinationals 5 History
Premium Pharmaceutical industry Pharmacology Clinical trial